Incyte Corp Clinical Trials

Determine Incyte Corp go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

A sample of Incyte Corp Clinical Trials data

Trial Title Trial Identifier Drug Name Therapy Area Indication Trial Phase Trial Status Sponsor
Showing 3 of 410+ results. Subscribe to unlock more.
Deserunt mollit sunt Lorem GDCTXXXX Lorem Lorem Lorem XXXX Planned Pfizer Inc
Chemotherapy (Da-epoch+/-r) and Targeted Therapy (Tafasitamab) for the Treatment of Newly-diagnosed Philadelphia Chromosome Negative B Acute Lymphoblastic Leukemia GDCT0460691 tafasitamab Oncology Acute Lymphoblastic Lymphoma; Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia); B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia); Precursor B-Cell Lymphoblastic Leukemia-Lymphoma Phase II Planned University of Washington
Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma GDCT0459686 retifanlimab; ruxolitinib phosphate; trametinib dimethyl sulfoxide Oncology Metastatic Adenocarcinoma of The Pancreas; Neuroendocrine Carcinoma; Pancreatic Ductal Adenocarcinoma Phase I Planned University of Miami
A Single-arm, Open-label, Multicenter Phase II Clinical Study Evaluating the Safety and Efficacy of Tafasitamab in Combination with Lenalidomide in Patients with Relapsed or Refractory Diffuse Large B-cell Lymphoma GDCT0458500 lenalidomide; tafasitamab Infectious Disease; Oncology Chronic Lymphocytic Leukemia (CLL); Diffuse Large B-Cell Lymphoma; Epstein–Barr Virus (HHV-4) Infections; Follicular Lymphoma; Marginal Zone B-cell Lymphoma; Unspecified B-Cell Lymphomas Phase II Planned Boehringer Ingelheim International GmbH
Clinical Trials

Feature

GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.

The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.

Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:

  • 250+ clinical trial registries
  • 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.

Benefit

The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).

Access:

  • Detailed trial information.
  • Drug information.
  • Patient information, including inclusion and exclusion criteria.
  • Trial results, as reported in the public domain.
  • Biomarkers used for patient stratification/selection & outcome measures.
  • Enrolment parameters.
  • Investigators involved in clinical trials.
  • Trials sites and locations.
  • Contact information.

Value

Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.

Geographic Analysis - see where trials are being run.

Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.

Find information on trials contacts, as well as Site and Investigator information.

Get information on trial successes and failures.

Get intelligence on CROs engaged in clinical trials.

Use as a business development tool for CROs.

Premium databases is part of our industry range of products

Subscribe to Company Analytics & gain 12-month access to premium industry data & analytics
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer